Reduced expression of the G209A α-synuclein allele in familial parkinsonism

Katerina Markopoulou, Zbigniew K. Wszolek, Ronald F. Pfeiffer, Bruce A Chase

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Missense mutations at the α-synuclein gene have been associated with familial parkinsonism. We report that the phenotype of a kindred (Family H) with autosomal dominant, levodopa-responsive parkinsonism maps to chromosomal region 4q21-23 and that affected members of this kindred harbor a previously reported mutation (G209A) in exon 4 of the α-synuclein gene. We assessed the expression of the G209A allele in lymphoblastoid cell lines established from 12 individuals heterozygous for the G209A allele. The expression of this allele is either absent or significantly reduced in 7 affected heterozygotes and in 3 asymptomatic heterozygotes who are older than the mean age at disease diagnosis for their generation. In contrast, it is expressed in 1 affected and 1 unaffected heterozygote. The unaffected heterozygote is younger than the mean age at disease diagnosis for their generation. The lack of or significantly reduced expression of the G209A allele in affected heterozygotes suggests that the timing of reduced expression may be critical for disease onset. If so, the parkinsonian phenotype may arise from haploinsufficiency at the α-synuclein gene at a time point before symptom onset. In conclusion, reduced α-synuclein gene expression may be important in the pathogenesis of parkinsonism.

Original languageEnglish (US)
Pages (from-to)374-381
Number of pages8
JournalAnnals of Neurology
Volume46
Issue number3
DOIs
StatePublished - Sep 13 1999

Fingerprint

Synucleins
Parkinsonian Disorders
Heterozygote
Alleles
Genes
Phenotype
Haploinsufficiency
Levodopa
Missense Mutation
Exons
Gene Expression
Cell Line
Mutation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Reduced expression of the G209A α-synuclein allele in familial parkinsonism. / Markopoulou, Katerina; Wszolek, Zbigniew K.; Pfeiffer, Ronald F.; Chase, Bruce A.

In: Annals of Neurology, Vol. 46, No. 3, 13.09.1999, p. 374-381.

Research output: Contribution to journalArticle

Markopoulou, Katerina ; Wszolek, Zbigniew K. ; Pfeiffer, Ronald F. ; Chase, Bruce A. / Reduced expression of the G209A α-synuclein allele in familial parkinsonism. In: Annals of Neurology. 1999 ; Vol. 46, No. 3. pp. 374-381.
@article{ce1745d2e5964f3780f1250369cea717,
title = "Reduced expression of the G209A α-synuclein allele in familial parkinsonism",
abstract = "Missense mutations at the α-synuclein gene have been associated with familial parkinsonism. We report that the phenotype of a kindred (Family H) with autosomal dominant, levodopa-responsive parkinsonism maps to chromosomal region 4q21-23 and that affected members of this kindred harbor a previously reported mutation (G209A) in exon 4 of the α-synuclein gene. We assessed the expression of the G209A allele in lymphoblastoid cell lines established from 12 individuals heterozygous for the G209A allele. The expression of this allele is either absent or significantly reduced in 7 affected heterozygotes and in 3 asymptomatic heterozygotes who are older than the mean age at disease diagnosis for their generation. In contrast, it is expressed in 1 affected and 1 unaffected heterozygote. The unaffected heterozygote is younger than the mean age at disease diagnosis for their generation. The lack of or significantly reduced expression of the G209A allele in affected heterozygotes suggests that the timing of reduced expression may be critical for disease onset. If so, the parkinsonian phenotype may arise from haploinsufficiency at the α-synuclein gene at a time point before symptom onset. In conclusion, reduced α-synuclein gene expression may be important in the pathogenesis of parkinsonism.",
author = "Katerina Markopoulou and Wszolek, {Zbigniew K.} and Pfeiffer, {Ronald F.} and Chase, {Bruce A}",
year = "1999",
month = "9",
day = "13",
doi = "10.1002/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9",
language = "English (US)",
volume = "46",
pages = "374--381",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Reduced expression of the G209A α-synuclein allele in familial parkinsonism

AU - Markopoulou, Katerina

AU - Wszolek, Zbigniew K.

AU - Pfeiffer, Ronald F.

AU - Chase, Bruce A

PY - 1999/9/13

Y1 - 1999/9/13

N2 - Missense mutations at the α-synuclein gene have been associated with familial parkinsonism. We report that the phenotype of a kindred (Family H) with autosomal dominant, levodopa-responsive parkinsonism maps to chromosomal region 4q21-23 and that affected members of this kindred harbor a previously reported mutation (G209A) in exon 4 of the α-synuclein gene. We assessed the expression of the G209A allele in lymphoblastoid cell lines established from 12 individuals heterozygous for the G209A allele. The expression of this allele is either absent or significantly reduced in 7 affected heterozygotes and in 3 asymptomatic heterozygotes who are older than the mean age at disease diagnosis for their generation. In contrast, it is expressed in 1 affected and 1 unaffected heterozygote. The unaffected heterozygote is younger than the mean age at disease diagnosis for their generation. The lack of or significantly reduced expression of the G209A allele in affected heterozygotes suggests that the timing of reduced expression may be critical for disease onset. If so, the parkinsonian phenotype may arise from haploinsufficiency at the α-synuclein gene at a time point before symptom onset. In conclusion, reduced α-synuclein gene expression may be important in the pathogenesis of parkinsonism.

AB - Missense mutations at the α-synuclein gene have been associated with familial parkinsonism. We report that the phenotype of a kindred (Family H) with autosomal dominant, levodopa-responsive parkinsonism maps to chromosomal region 4q21-23 and that affected members of this kindred harbor a previously reported mutation (G209A) in exon 4 of the α-synuclein gene. We assessed the expression of the G209A allele in lymphoblastoid cell lines established from 12 individuals heterozygous for the G209A allele. The expression of this allele is either absent or significantly reduced in 7 affected heterozygotes and in 3 asymptomatic heterozygotes who are older than the mean age at disease diagnosis for their generation. In contrast, it is expressed in 1 affected and 1 unaffected heterozygote. The unaffected heterozygote is younger than the mean age at disease diagnosis for their generation. The lack of or significantly reduced expression of the G209A allele in affected heterozygotes suggests that the timing of reduced expression may be critical for disease onset. If so, the parkinsonian phenotype may arise from haploinsufficiency at the α-synuclein gene at a time point before symptom onset. In conclusion, reduced α-synuclein gene expression may be important in the pathogenesis of parkinsonism.

UR - http://www.scopus.com/inward/record.url?scp=0032835781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032835781&partnerID=8YFLogxK

U2 - 10.1002/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9

DO - 10.1002/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9

M3 - Article

VL - 46

SP - 374

EP - 381

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 3

ER -